Surgical Treatments of Chronic Idiopathic Thrombocytopenic Purpura and Prognostic Factors for Splenectomy

International Surgery

Volumn 81, Issue 2, 1996, Pages 140-143

  Shiino, Y ^a   Takahashi, N ^a   Okamoto, T ^a   Ishii, Y ^a   Yanagisawa, A ^a   Inagaki, Y ^a   Aoki, T ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ITP; Multivariate analysis; Prognostic factor; Splenectomy

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; THROMBOCYTE ANTIBODY;

ACCESSORY SPLEEN; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLEEDING TIME; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PROGNOSIS; SPLENECTOMY; STEROID THERAPY; THROMBOCYTE COUNT; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPLENECTOMY;

EID: 0029952931     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Karpatkin S, Siskind GW. In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood 1969;33:795-812.
2. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981;304:1135-1147.
3. Karpatkin S, Strick N, Siskind GW. Detection of splenic antiplatelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol 1972;23:167-176.
4. Imbach P, Barandun S, d'Apuzzo V et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-1231.
5. Finch SC, Castro O, Cooper M, Covey W, Erichson R, McPhedran P. Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med 1974;56:4-12.
6. Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG. Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 1983;308:1396-1399.
7. Ahn YS, Harrington WJ, Mylvaganam R, Allen LM, Pall LM. Slow infusion of vinca alkaloids in the treatment of idiopathic thrombocytopenic purpura. Ann Intern Med 1984:100:192-196.
8. Brox AG, Howson Jan K, Fauser AA. Treatment of idiopathic thrombocytopenic purpura with ascorbate. Br J Haematol 1988; 70:341-344.
9. Proctor SJ, Jackson G, Carey P et. al. Improvement of platelet counts in steroid unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood 1989:74:1894-1897.
10. Lusher JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in childhood. J Pediatr 1966;68:971-979.
11. Karpatkin S. Autoimmune thrombocytopenic purpura. Blood 1980;56:329-343.
12. Dan K, Gomi S, Kuramoto A, Maekawa T, Nomura T. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura. Int J Hematol 1992;55:287-292.
13. Robson HN, Davidson LSP. Purpura in pregnancy with special reference to idiopathic thrombocytopenic purpura. Lancet 1950; 259:164-169.
14. Evans RS, Takahashi K, Duane RT, Payne R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. Arch Intern Med 1951;87:48-65.
15. Chirletti P, Cardi M, Barillari P et al. Surgical treatment of immune thrombocytopenic purpura. World J Surg 1992;16:1001-1004.
16. Naouri A, Feghali B, Chabal M et al. Results of splenectomy for idiopathic thrombocytopenic purpura. Review of 72 cases. Acta Haematol 1993;89:200-203.
17. DiFino SM, Lachant NA, Kirshner JJ, Gottlieb AJ. Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 1980;69:430-442.
18. Thompson RL, Moore RA, Hess CE, Wheby MS, Leavell BS. Idiopathic thrombocytopenic purpura. Long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Intern Med 1972;130:730-734.
19. Gugliotta L, Isacchi G, Guarini A et al. Chronic idiopathic thrombocytopenic purpura (ITP): site of platelet sequestration and results of splenectomy. A study of 197 patients. Scand J Haematol 1981;26:407-412.
20. JiJi RM, Firozvi T, Spurling CL. Chronic idiopathic thrombocytopenic purpura. Treatment with steroids and splenectomy. Arch Intern Med 1973;132:380-383.
21. den Ottolander GJ, Gratama JW, de Koning J, Brand ATI. Long-term follow-up study of 168 patients with immune thrombocytopenia. Implications for therapy. Scand J Haematol 1984;32:101-110.
22. Najean Y, Dufour V, Rain JD, Toubert ME. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. Br J Haematol 1991;79:271-276.
23. Verheyden CN, Beart RW jr, Clifton MD, Phyliky RL. Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura. Mayo Clin Proc 1978;53:442-446.
24. Pohlson EC, Wilkinson RW, Witzum KF, Coel MN. Heat-damaged red cell scan for intraoperative localization of the accessory spleen. J Pediatr Surg 1994;29:604-608.
25. Facon T, Caulier MT, Fenaux P et al. Accessory spleen in recurrent chronic immune thrombocytopenic purpura. Am J Hematol 1992;41:184-189.
26. Eraklis AJ, Kevy SV, Diamond LK, Gross RE. Hazard of overwhelming infection after splenectomy in childhood. N Engl J Med 1967;276:1225-1229.
27. Whitaker AN. Infection and the spleen: association between hyposplenism, pneumococcal sepsis and disseminated intravascular coagulation. Med J Aust 1969;1:1213-1219.
28. Winkelstein JA, Drachman RH. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. N Engl J Med 1968; 279:459-466.
29. Rabiner SF, Friedman LH. The role of intravascular haemolysis and the reticulo-endothelial system in the production of a hypercoagulable state. Br J Haematol 1968;14:105-118.
30. Baldini M. Idiopathic thrombocytopenic purpura. N Engl J Med 1966;274:1245-1251.